Bill Miller Karuna Therapeutics, Inc. Transaction History

Miller Value Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $3.23 Million - $4.09 Million	20,032 Added 13.82%	164,998 $30 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $4.86 Million - $6.01 Million	-25,369 Reduced 14.89%	144,966 $28.5 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $6.51 Million - $14.6 Million	-52,620 Reduced 23.6%	170,335 $38.3 Million
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $1.78 Million - $2.71 Million	-18,893 Reduced 7.81%	222,955 $28.2 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $51,922 - $69,494	525 Added 0.22%	241,848 $30.7 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $209,994 - $302,541	1,898 Added 0.79%	241,323 $31.6 Million
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $5.86 Million - $7.28 Million	-57,864 Reduced 19.46%	239,425 $29.3 Million
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $650,072 - $822,497	6,050 Added 2.08%	297,289 $33.9 Million
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $27.8 Million - $38.8 Million	291,239 New	291,239 $35 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.